Tag: Avenue Therapeutics
December 11, 2019
Avenue Therapeutics Submits New Drug Application for IV Tramadol
The company submitted a new drug application to the US Food and Drug Administration for its treatment IV tramadol.
July 4, 2019
5 Top NASDAQ Pharma Stocks Year-to-Date
We're halfway through the year, which means it's time to reflect on the top performing NASDAQ pharma stocks year-to-date.
June 9, 2019
5 Top Weekly NASDAQ Biotech and Pharma Stocks: La Jolla Soars
INN looks at the top NASDAQ biotech and pharma stocks over the course of the week and what may have... December 19, 2018
Avenue Therapeutics Announces Dosing of First Patient in Second Pivotal Phase 3 Clinical Trial
Avenue Therapeutics (NASDAQ:ATXI) a specialty pharmaceutical company focused on the development and commercialization of intravenous (IV) tramadol, today announced that...
November 18, 2018